癌症治疗中METTL3抑制剂的最新进展:设计,优化和潜在的应用
Yun Zhang1, Mengxiang Quan1, Qinlan Chen2
1Affiliated Yongkang First People's Hospital and School of Pharmacy, Hangzhou Medical College Hangzhou 310013 China wzuny@hmc.edu.cn.
RSC medicinal chemistry
|January 23, 2026
概括
甲基转移酶样蛋白3 (METTL3) 是急性髓性白血病 (AML) 的关键驱动因素. 开发METTL3抑制剂提供了一个有希望的新策略,以克服AML治疗中的耐药性.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药用化学 医学化学
背景情况:
- 急性髓性白血病 (AML) 是一种常见的成人白血病,其特征是血液形成分化受阻.
- 甲基转移酶样蛋白3 (METTL3) 在AML中过度表达,并驱动白血病发生.
- 向METTL3为AML提供了一个新的治疗途径,可能克服化疗耐药性.
研究的目的:
- 审查发现和优化METTL3抑制剂的策略.
- 为未来的AML药物开发提供参考.
- 探索METTL3抑制剂的临床应用前景.
主要方法:
- 医学化学策略的文献综述.
- 分析METTL3在AML病变发生中的作用.
- 对METTL3抑制剂的药物发现和优化方法的评估.
主要成果:
- METTL3是AML中验证的治疗标.
- 为了设计和改进METTL3抑制剂,存在各种策略.
- 抑制METTL3显示出克服耐药性的潜力.
结论:
- METTL3 抑制剂代表了AML治疗的重大进展.
- 进一步的药物化学研究对于开发有效的METTL3向药物至关重要.
- METTL3 抑制剂对AML患者的改善临床结果有希望.
相关概念视频
mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
Design Example: Application of Archimedes' Principle
803
Archimedes' principle is fundamental in analyzing the buoyant force and stability of floating bodies. In this example, a wooden block with a rectangular section floats in seawater. Based on the block's dimensions, its specific gravity and the specific weight of seawater are used to find the volume of water displaced and the center of buoyancy.
The volume of seawater displaced by the block is determined by first calculating the block's weight. This is done by multiplying the...
The volume of seawater displaced by the block is determined by first calculating the block's weight. This is done by multiplying the...
803
Group Design
10.3K
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
10.3K
Eukaryotic Transcription Inhibitors
10.9K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Factorial Design
13.7K
Factorial Analysis is an experimental design that applies Analysis of Variance (ANOVA) statistical procedures to examine a change in a dependent variable due to more than one independent variable, also known as factors. Changes in worker productivity can be reasoned, for example, to be influenced by salary and other conditions, such as skill level. One way to test this hypothesis is by categorizing salary into three levels (low, moderate, and high) and skills sets into two levels (entry level...
13.7K
Tumor Progression
7.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K


